# A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers

> **NCT00923533** · PHASE1 · COMPLETED · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 34 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Fimasartan
- **DRUG:** Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00923533
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-05
- **Final completion:** 2009-08
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2009-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00923533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00923533, "A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00923533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*